Ameriprise’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-116,751
| Closed | -$100K | – | 3994 |
|
|
2023
Q4 | $100K | Buy |
116,751
+35,340
| +43% | +$30.4K | ﹤0.01% | 3814 |
|
|
2023
Q3 | $87.1K | Hold |
81,411
| – | – | ﹤0.01% | 3809 |
|
|
2023
Q2 | $211K | Sell |
81,411
-2,201
| -3% | -$5.7K | ﹤0.01% | 3714 |
|
|
2023
Q1 | $341K | Buy |
83,612
+35,225
| +73% | +$144K | ﹤0.01% | 3569 |
|
|
2022
Q4 | $244K | Buy |
+48,387
| New | +$244K | ﹤0.01% | 3654 |
|